NTRS
62
5
NWL
54
5
GIS
31
2
JWN
67
2
MCD
65
2
MO
38
2
EMC
68
6
ORCL
65
2
F
47
3
UPS
48
5
RSG
70
2
SYK
51
3
EXPD
48
3
HAL
50
2
VMC
63
10
K
56
2
AES
37
4
PHM
68
3
CNP
65
3
MA
69
5
NTRS
62
5
NWL
54
5
GIS
31
2
JWN
67
2
MCD
65
2
MO
38
2
EMC
68
6
ORCL
65
2
F
47
3
UPS
48
5
RSG
70
2
SYK
51
3
EXPD
48
3
HAL
50
2
VMC
63
10
K
56
2
AES
37
4
PHM
68
3
CNP
65
3
MA
69
5
Financhill
Back

ProShares Short Financials Vs. Kymera Therapeutics Industry Stock Comparison

Sell
27

SEF
ProShares Short Financials

Last Price:
9.08
Seasonality Move:
-7.73%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
47.65
Seasonality Move:
65.72%
Sell
27
ProShares Short Financials (SEF) is a Sell

Is ProShares Short Financials a Buy, Sell or Hold?

  • The current ProShares Short Financials [SEF] share price is $9.12. The Score for SEF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • SEF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SEF Stock Price Chart

What is ProShares Short Financials's stock price today?

  • The ProShares Short Financials share price today is $9.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEF is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SEF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 27.75 Sell
Chaikin Money Flow: -18452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.38 - 9.7) Sell
Bollinger Bands (100): (9.61 - 10.45) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

SEF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.36 Sell
20-day SMA: 9.49 Sell
50-day SMA: 9.71 Sell
200-day SMA: 10.39 Sell
8-day EMA: 9.32 Sell
20-day EMA: 9.46 Sell
50-day EMA: 9.68 Sell
200-day EMA: 10.46 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Short Financials Earnings Growth & SEF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Short Financials Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):